Angiodynamics (ANGO) Change in Receivables (2010 - 2026)

Angiodynamics has reported Change in Receivables for 17 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 199.16% year-over-year to $1.4 million; the trailing twelve-month figure through Feb 2026 stood at $2.4 million (up 146.83% YoY), and the FY2025 full-year result was -$23000.0, up 99.71% from the prior year.
• Change in Receivables for Q1 2026 stood at $1.4 million, down from $1.6 million in the prior quarter.
• The five-year high for Change in Receivables was $10.7 million in Q2 2022, with the low at -$5.5 million in Q2 2024.
• Historically, Change in Receivables has averaged $615176.5 across 5 years, with a median of $474000.0 in 2025.
• Annual changes were most pronounced in 2022 — Change in Receivables soared 3858.33% — and 2024, when it sank 369.63%.
• Angiodynamics' Change in Receivables stood at -$406000.0 in 2022, then jumped by 710.84% to $2.5 million in 2023, then jumped by 50.56% to $3.7 million in 2024, then tumbled by 58.01% to $1.6 million in 2025, then declined by 9.57% to $1.4 million in 2026.
• The last three Change in Receivables figures came in at $1.4 million (Q1 2026), $1.6 million (Q4 2025), and -$139000.0 (Q3 2025), per Business Quant data.